Degradation of the Id2 developmental regulator: Targeting via N-terminal ubiquitination

Biochemical and Biophysical Research Communications

Volumn 314, Issue 2, 2004, Pages 505-512

  Fajerman, Ifat ^a   Schwartz, Alan L ^b   Ciechanover, Aaron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INHIBITOR OF DIFFERENTIATION 2; POLYUBIQUITIN; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; UBIQUITINATION;

EID: 0345743607     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.116     Document Type: Article

References (32)

1. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:2002;373-428.
2. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:2001;503-533.
3. Voges D., Zwickl P., Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1999;1015-1068.
4. Breitschopf K., Bengal E., Ziv T., Admon A., Ciechanover A. A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J. 17:1998;5964-5973.
5. 2-terminal residue. J. Biol. Chem. 275:2000;23491-23499.
6. Ikeda M., Ikeda A., Longnecker R. Lysine-independent ubiquitination of Epstein-Barr virus LMP2A. Virology. 300:2002;153-159.
7. Reinstein E., Scheffner M., Oren M., Ciechanover A., Schwartz A.L. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene. 19:2000;5944-5950.
8. Bloom J., Amador V., Bartolini F., DeMartino G., Pagano M. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell. 115:2003;71-82.
9. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. USA. 93:1996;12142-12149.
10. Johnson E.S., Ma P.C., Ota I.M., Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270:1995;17442-17456.
11. Massari M.E., Murre C. Helix-loop-helix proteins: regulators of transcription in eukaryotic organisms. Mol. Cell. Biol. 20:2000;429-440.
12. Murre C., McCaw P.S., Vaessin H., Caudy M., Jan L.Y., Jan Y.N., Cabrera C.V., Buskin J.N., Hauschka S.D., Lassar A.B., Weintraub H., Baltimore D. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell. 58:1989;537-544.
13. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:1990;49-59.
14. Norton J.D. Id helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113:2000;3897-3905.
15. Israel M.A., Hernandez M.C., Florio M., Andres-Barquin P., Mantani A., Carter J.H., Jullin C.M. Id gene expression as a key mediator of tumour cell biology. Cancer Res. 59:1999;1726s-1730s.
16. Lasorella A., Uo T., Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene. 20:2001;8326-8333.
17. Norton J.D., Craggs G., Deed R.W., Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 8:1998;58-65.
18. Hara E., Yamaguchi T., Nojima H., Ide T., Campisi J., Okayama H., Oda K. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem. 269:1994;2139-2145.
19. Iavarone A., Garg P., Lasorella A., Hsu J., Israel M.A. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8:1994;1270-1284.
20. Hara E., Hall M., Peters G. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. EMBO J. 16:1997;332-342.
21. Deed R.W., Hara E., Atherton G.T., Peters G., Norton J.D. Regulation of Id3 cell cycle function by Cdk2-dependent phosphorylation. Mol. Cell. Biol. 17:1997;6815-6821.
22. Bounpheng M.A., Dimas J.J., Dodds S.G., Christy B.A. Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J. 13:1999;2257-2264.
23. Guan J.L., Rose J.K. Conversion of a secretory protein into a transmembrane protein results in its transport to the Golgi complex but not to the cell surface. Cell. 37:1984;779-787.
24. Salvat C., Acquaviva C., Scheffner M., Robbins I., Piechaczyk M., Jariel-Encontre I. Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20: requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo. Eur. J. Biochem. 267:2000;3712-3722.
25. β-TrCP ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase. EMBO J. 19:2000;2580-2591.
26. Orian A., Whiteside S., Israël A., Stancovski I., Schwartz A.L., Ciechanover A. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2 and a novel ubiquitin-protein ligase, E3, involved in conjugation. J. Biol. Chem. 270:1995;21707-21714.
27. Hershko A., Heller H. Occurrence of a polyubiquitin structure in ubiquitin-protein conjugates. Biochem. Biophys. Res. Commun. 128:1985;1079-1086.
28. Hershko A., Rose I.A. Ubiquitin-aldehyde: a general inhibitor of ubiquitin recycling processes. Proc. Natl. Acad. Sci. USA. 84:1987;1829-1833.
29. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
30. Johnston N.L., Cohen R.E. Uncoupling ubiquitin-protein conjugation from ubiquitin-dependent proteolysis by use of β,γ-nonhydrolyzable ATP analogues. Biochemistry. 30:1991;7514-7522.
31. King R.W., Glotzer M., Kirschner M.W. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates. Mol. Biol. Cell. 7:1996;1343-1357.
32. Hou D., Cenciarelli C., Jensen J.P., Nguygen H.B., Weissman A.M. Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines. J. Biol. Chem. 269:1994;14244-14247.